Biofem
Biofem Group is a Nigerian pharmaceutical and healthcare distributor founded in 2002 that imports and markets medicines, medical devices, supplements, and functional foods through a nationwide medical representative network, with additional operations in Ghana.
- Company typePrivate
- Founded2002
- HeadquartersIkeja, Nigeria
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biofem does
Biofem Group is a privately held Nigerian pharmaceutical and healthcare distribution company headquartered in Ikeja, Lagos, operating since 2002. The company imports, distributes, and markets a diversified portfolio of pharmaceutical products, medical devices, dietary supplements, and functional food products through wholly-owned subsidiaries including Biofem Pharmaceuticals Ltd, Biofem Specialties, Biofem Medical Devices, Biofem Foods, Biofem Farms, Biofem Oil and Gas, and Biofem Ghana. Its product range spans prescription pharmaceuticals (Biobetic for diabetes, RhoGam Anti-D, Uman Albumin, Laxgo, Stoptrans), diagnostic medical devices (SDA1C HbA1c machine for diabetes monitoring), multivitamin and cod liver oil supplements (DCALC, Biosea), and food products (Garlic Powder, Turmeric Powder).
Biofem's go-to-market is anchored on a direct medical representative network strategically distributed across Nigeria, complemented by a wholly-owned Ghana operation. The company positions itself as a global pioneer in Mobile Authentication System (MAS) technology for pharmaceutical product verification, addressing Nigeria's counterfeit drug problem. Its marketing relies primarily on educational blog content (diabetes awareness, maternal health, wellness) and organic social media rather than paid digital advertising at scale.
The business model is distribution-led with revenue generated from pharmaceutical and supplement sales to healthcare consumers, diabetes patients, and expecting mothers across Nigeria and Ghana. Pricing is not publicly disclosed, and there is no named enterprise customer base — implying a long-tail consumer and pharmacy-channel mix. The company has expanded laterally into non-healthcare verticals (farming, oil and gas) and maintains a US-affiliated entity, suggesting either sourcing arrangements or capital diversification beyond the core pharma business. No funding rounds, M&A activity, or disclosed financial figures appear in the available source material.
Biofem firmographics
Firmographics- Name
- Biofem
- Legal name
- Biofem Group
- Website
- https://biofemgroup.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biofem Group is a Nigerian pharmaceutical and healthcare distributor founded in 2002 that imports and markets medicines, medical devices, supplements, and functional foods through a nationwide medical representative network, with additional operations in Ghana.
- Ownership category
- akta.pro rank
Biofem industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industry
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
Keywords
Where Biofem is headquartered
LocationHeadquarters
- HQ city
- Ikeja
- HQ country
- Nigeria
- HQ region
- Africa
Offices1 record
Markets served
Biofem business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels2 records
Biofem product offering
Product offeringCore offering
Biofem imports, distributes and markets pharmaceutical products and medical devices across Nigeria and Ghana, operating through subsidiaries that handle prescription medicines, specialty supplements, medical devices (notably for diabetes and maternal health), and food/wellness products. Its portfolio includes the Biobetic diabetes brand, the SDA1C HbA1c monitoring machine, DCALC multivitamins, Biosea cod liver oil, RhoGam Anti-D, Uman Albumin, Laxgo, and Stoptrans, complemented by its proprietary Mobile Authentication System (MAS) for product verification.
Product overview
Biofem is a diversified pharmaceutical and healthcare company operating multiple divisions including Biofem Pharmaceuticals Ltd (high-quality pharmaceuticals), Biofem Specialties (specialty supplements), Biofem Medical Devices (diagnostic devices including HbA1c machines), and Biofem Foods (dietary supplements and food products). The portfolio spans prescription pharmaceuticals, over-the-counter medications, medical devices for disease detection (particularly diabetes management), nutritional supplements including multivitamins and cod liver oil, and functional food products. The company serves patients across Nigeria and Ghana with products focused on chronic disease management, maternal health, and general wellness.
Differentiator
Problem solved
Functional benefit
Brands
- Biobetic: Pharmaceutical product by Biofem Pharmaceuticals for diabetes management
- Right2Life
- LiveItUp
- Mother and Child
- PioneerMAS
- Codefree
- Biosea
- RhoGam Anti-D
Products and services
- Biobetic Pharmaceutical product marketed by Biofem Pharmaceuticals for diabetes management and blood sugar control.
- SDA1C Machine A medical device for measuring HbA1c (glycated hemoglobin) levels, used for diabetes diagnosis and monitoring.
- DCALC Multivitamins A multivitamin supplement marketed by Biofem Specialties for general health and nutritional support.
- Garlic Powder A food product from Biofem Foods, providing dietary garlic supplement in powder form.
- Turmeric Powder A food product from Biofem Foods, providing dietary turmeric supplement in powder form.
- Biosea Cod Liver Oil A cod liver oil supplement for nutritional support including omega-3 fatty acids.
- RhoGam Anti-D An anti-D immunoglobulin pharmaceutical product used for Rh prophylaxis in pregnancy.
- Uman Albumin A human albumin pharmaceutical product used for blood volume expansion and treatment of hypoalbuminemia.
- Laxgo A pharmaceutical laxative product for constipation relief.
- Stoptrans A pharmaceutical product positioned as a hemostatic or anti-hemorrhagic agent.
Companies that use Biofem
Customer profileSegments3 records
Ideal customer profiles3 records
Biofem technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature1 record
Biofem partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
Biofem competitors and assessment
Company assessmentBroad incumbents
- Sanofi Nigeria: Subsidiary of a global pharmaceutical company marketing prescription drugs, vaccines, and consumer health products in Nigeria. Comparable to Biofem as a multinational distributor competing for the same chronic-disease and consumer-health customers.
- GlaxoSmithKline Consumer Nigeria (Haleon): Nigeria operations of a global consumer healthcare company selling OTC medicines, vitamins, and wellness products. Comparable to Biofem on the OTC and consumer-health distribution side, especially for supplements and wellness SKUs such as DCALC and Biosea.
- Novartis Nigeria: Subsidiary of a global pharmaceutical major distributing specialty medicines in Nigeria including cardiovascular and chronic-disease therapies. Overlaps with Biofem's chronic-care distribution footprint.
- AstraZeneca Nigeria: Subsidiary of a global biopharmaceutical company marketing specialty and chronic-disease medicines in Nigeria. Comparable to Biofem in distributing biologics and prescription products into Nigeria's regulated healthcare channel.
- Pfizer Nigeria: Subsidiary of a global biopharmaceutical major distributing a portfolio of vaccines, biologics, and prescription medicines in Nigeria. Comparable as a competing biologics-and-pharma distributor operating in the same NAFDAC-regulated channel.
Direct peers
- Chi Pharmaceuticals: Nigerian pharmaceutical company focused on manufacturing and marketing prescription and OTC medicines, including antimalarials and chronic-disease therapies. Directly comparable to Biofem in target market, distribution model, and disease-area focus.
- Fidson Healthcare: Nigerian pharmaceutical manufacturer and marketer listed on the Nigerian Stock Exchange with a portfolio spanning prescription drugs, OTCs, and consumer health. Comparable to Biofem in product breadth, distribution model, and target customer segments within Nigeria.
- Emzor Pharmaceutical Industries: One of Nigeria's largest indigenous pharmaceutical manufacturers and distributors with a broad prescription, OTC, and supplement portfolio serving nationwide channels. Directly comparable to Biofem as a Nigeria-based pharma company competing in the same disease areas and retail/wholesale channels.
- May & Baker Nigeria: Long-established Nigerian pharmaceutical manufacturer with a portfolio of prescription medicines, infusions, and consumer health products distributed nationwide. Comparable to Biofem as a Nigeria-based pharma distribution peer with overlapping therapeutic categories and OTC presence.
- Afrab-Chem Limited: Nigerian pharmaceutical manufacturer and distributor of OTC, prescription, and consumer health products operating across Nigeria and West Africa. Comparable to Biofem as a domestically headquartered pharma distribution peer with regional ambitions.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Biofem social profiles
Digital presenceBiofem compliance and trust
Trust signalCompliance2 records
Biofem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biofem leadership team
Management profileNumber of profiles
Profiles2 records
Biofem subsidiaries and ownership
Company hierarchySubsidiaries8 records
Biofem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biofem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biofem
What does Biofem do?
Biofem imports, distributes and markets pharmaceutical products and medical devices across Nigeria and Ghana, operating through subsidiaries that handle prescription medicines, specialty supplements, medical devices (notably for diabetes and maternal health), and food/wellness products. Its portfolio includes the Biobetic diabetes brand, the SDA1C HbA1c monitoring machine, DCALC multivitamins, Biosea cod liver oil, RhoGam Anti-D, Uman Albumin, Laxgo, and Stoptrans, complemented by its proprietary Mobile Authentication System (MAS) for product verification.
Is Biofem a public or private company?
Biofem is a private company. It is classified as unknown and is currently operating.
When was Biofem founded?
Biofem was founded in 2002. It employs 11 to 50 people.
Where is Biofem based?
Biofem is headquartered in Ikeja, Nigeria, in the Africa region.
Who are Biofem's main competitors?
Broad incumbents on record are Sanofi Nigeria, GlaxoSmithKline Consumer Nigeria (Haleon), Novartis Nigeria, AstraZeneca Nigeria and Pfizer Nigeria. Direct peers are Chi Pharmaceuticals, Fidson Healthcare, Emzor Pharmaceutical Industries, May & Baker Nigeria and Afrab-Chem Limited.
Does Biofem have an API?
No public API is recorded for Biofem.
What industry is Biofem in?
Biofem's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 325412 and its SIC code is 5122.